NEW DELHI, Jan 3 (Reuters) - India's drugs regulator said on Sunday it had given final emergency-use approval for two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech. (Reporting by Aftab Ahmed and Nigam Prusty: Editing by Neil Fullick)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,424 INR | +1.70% | +0.17% | -1.73% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
12,050 GBX | -0.87% | +0.52% | 234B | ||
997.4 INR | +0.95% | +5.28% | 12.04B | ||
1st Jan change | Capi. | |
---|---|---|
-1.73% | 1.63B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- ASTRAZEN Stock
- News AstraZeneca Pharma India Limited
- AstraZeneca Pharma India : India gives final urgent-use approval to AstraZeneca, local COVID vaccines